$-0.95
(Market cap
$3,703 Mln
Revenue (TTM)
$587 Mln
P/E Ratio
--
P/B Ratio
5.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.3 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
17.2
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-2.5
-
Face value
--
-
Shares outstanding
31,554,807
10 Years Aggregate
CFO
$-329.40 Mln
EBITDA
$-371.78 Mln
Net Profit
$-377.23 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
aTyr Pharma (LIFE)
| -- | 73.3 | 87.2 | -- | 175.1 | 45.0 | -1.4 |
|
BSE Sensex
| -9.1 | -1.5 | 2.9 | -3.6 | 5.9 | 6.0 | 10.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|---|---|---|---|---|---|---|---|
|
aTyr Pharma (LIFE)
| -35.6 | -70.7 | 92.5 | -7.0 | -39.9 | -85.7 | 62.8 |
|
S&P Small-Cap 600
| 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 | 11.7 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout aTyr Pharma (LIFE)
Ethos Technologies Inc. provides third-party administrator services for insurance policies in the United States. The company offers Ethos, a three-sided technology platform that serves an ecosystem of consumers, agents, and carriers. It also provides... term life insurance, whole life insurance, and indexed universal life insurance products, as well as wills and estate planning, and supplemental health insurance products. The company was formerly known as Ethos Insurance Corporation and changed its name to Ethos Technologies Inc. in August 2016. The company was incorporated in 2016 and is based in San Francisco, California. Read more
-
President, CEO & Director
Dr. Sanjay S. Shukla M.D., M.S.
-
President, CEO & Director
Dr. Sanjay S. Shukla M.D., M.S.
-
Headquarters
San Francisco, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for aTyr Pharma (LIFE)
What is the current share price of aTyr Pharma Inc (LIFE) Today?
The share price of aTyr Pharma Inc (LIFE) is $35.39 (NASDAQ) as of 01-Sep-2026 12:38 EDT. aTyr Pharma Inc (LIFE) has given a return of 175.08% in the last 3 years.
What is the current PB & PE ratio of aTyr Pharma Inc (LIFE)?
Since, TTM earnings of aTyr Pharma Inc (LIFE) is negative, P/E ratio is not available.
The P/B ratio of aTyr Pharma Inc (LIFE) is 5.29 times as on 28-Aug-2026, a 2 premium to its peers’ median range of 5.18 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-- |
-- |
2024 |
-- |
-- |
2023 |
-- |
-- |
2022 |
-- |
-- |
2021 |
-- |
-- |
What is the 52 Week High and Low of aTyr Pharma Inc (LIFE)?
The 52-week high and low of aTyr Pharma Inc (LIFE) are Rs 40.97 and Rs 9.69 as of 01-Sep-2026.
What is the market cap of aTyr Pharma Inc (LIFE)?
aTyr Pharma Inc (LIFE) has a market capitalisation of $ 3,703 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in aTyr Pharma Inc (LIFE)?
Before investing in aTyr Pharma Inc (LIFE), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.